Novo Nordisk | NVO - Umsatzerlöse

Aktienkurs
38.67
Täglich Wechseln
0.13 0.34%
Monatlich
-18.90%
Jährlich
-56.02%
Q1 Prognose
35.54




Der Umsatz Veränderung Datum
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Aurora Cannabis CAD 90.37M 7.65M 2025-09
Bausch Health Companies USD 2.8B 120M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Novartis USD 13.91B 144M 2025-09
Novo Nordisk DKK 79.14B 4.16B 2025-12
Novo Nordisk DKK 12.53B 560M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Phibro Animal Health USD 309.26M 48.83M 2024-12
Prestige Brands USD 283.44M 9.34M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Zoetis USD 2.4B 0 2025-12